GREGORY MCFALL: Open Payments
NPI 1861168676 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 3 | $142 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| Lundbeck LLC | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: Qelbree, HETLIOZ, REXULTI, CAPLYTA, Auvelity, COBENFY.
Industry payments across KY — which companies pay providers there.
